The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset (Q33873941)

29 July 2017

title

The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset (English)

1 reference

29 July 2017

1 reference

Constantine G. Lyketsos

series ordinal

4

object named as

Constantine G Lyketsos

1 reference

29 July 2017

Joann T Tschanz

1

1 reference

29 July 2017

Maria C Norton

series ordinal

2

1 reference

29 July 2017

Peter P Zandi

series ordinal

3

1 reference

29 July 2017

publication date

1 December 2013

1 reference

International Review of Psychiatry

29 July 2017

published in

1 reference

29 July 2017

volume

25

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

673-685

1 reference

Impact of offspring death on cognitive health in late life: the Cache County study

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Caregiver personality predicts rate of cognitive decline in a community sample of persons with Alzheimer's disease. The Cache County Dementia Progression Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Challenges of diagnosing dementia in the oldest old population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Predictors of dementia caregiver depressive symptoms in a population: the Cache County dementia progression study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Predictors of progression to severe Alzheimer's disease in an incidence sample

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Stressful life events and cognitive decline in late life: moderation by education and age. The Cache County Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Baseline disability in activities of daily living predicts dementia risk even after controlling for baseline global cognitive ability and depressive symptoms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Caregivers' relationship closeness with the person with dementia predicts both positive and negative outcomes for caregivers' physical health and psychological well-being

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: the Cache County study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Neuropsychiatric symptoms in Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Early parental death and remarriage of widowed parents as risk factors for Alzheimer disease: the Cache County study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Outcomes of mild cognitive impairment by definition: a population study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Interaction between vascular factors and the APOE ε4 allele in predicting rate of progression in Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Timing of hormone therapy and dementia: the critical window theory revisited

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Greater risk of dementia when spouse has dementia? The Cache County study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Dementia incidence continues to increase with age in the oldest old: the 90+ study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the cache county memory, health and aging study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Diet quality is associated with better cognitive test performance among aging men and women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Early parental death and late-life dementia risk: findings from the Cache County Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

A life course of adiposity and dementia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Prevalence of dementia in the United States: the aging, demographics, and memory study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Alzheimer's and dementia in the oldest-old: a century of challenges

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Mediterranean diet and risk for Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Aggregation of vascular risk factors and risk of incident Alzheimer disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Progress in clinical neurosciences: cognitive markers of progression in Alzheimer's disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Vitamin E and donepezil for the treatment of mild cognitive impairment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Use of ramipril in preventing stroke: double blind randomised trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

High-dose estradiol improves cognition for women with AD: results of a randomized study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Incidence of dementia: does gender make a difference?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation to the development of Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Statins and the risk of dementia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Early-life risk factors and the development of Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Factors affecting the age of onset and rate of progression of Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Assessment of progression and prognosis in 'possible' and 'probable' Alzheimer's disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory.

5 July 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Predicting the rate of cognitive decline in aging and early Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Natural history of Alzheimer's disease and other dementias: review of the literature in the light of the findings from the Kungsholmen Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Randomized pilot study of nimesulide treatment in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Dementia is not inevitable: a population-based study of Danish centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Referral bias in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Developmental and vascular risk factors for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Effects of estrogen plus progestin on risk of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Hormone replacement therapy and reduced cognitive decline in older women: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Grouping and trajectories of the neuropsychiatric symptoms in patients with Alzheimer's disease, part I: symptom clusters.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Dementia incidence may increase more slowly after age 90: results from the Bronx Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Does NSAID use modify cognitive trajectories in the elderly? The Cache County study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Antioxidant vitamin intake and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Incidence of AD may decline in the early 90s for men, later for women: The Cache County study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Vascular factors predict rate of progression in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Fish consumption and cognitive decline with age in a large community study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Hormone therapy and risk of Alzheimer disease: a critical time.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Long-term efficacy and safety of celecoxib in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

The persistence of neuropsychiatric symptoms in dementia: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Rate of memory decline in AD is related to education and occupation: cognitive reserve?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

A population study of Alzheimer's disease: findings from the Cache County Study on Memory, Health, and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Conversion to dementia from mild cognitive disorder: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Five-Year Follow-up of Cognitive Impairment With No Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Epidemiology of cognitive aging and Alzheimer's disease: contributions of the cache county utah study of memory, health and aging.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Antioxidant intake and cognitive function of elderly men and women: the Cache County Study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Clinicopathological analysis of dementia disorders in the elderly--an update.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Relationship of disease severity to decline on specific cognitive and functional measures in Alzheimer disease.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4089882

Behavioral Syndromes in Alzheimer’s Disease: Description and Correlates

29 October 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Statin Use and the Risk of Incident Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.849663

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24423221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24423221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of Estrogen Plus Progestin on Risk of Dementia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24423221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3109/09540261.2013.849663

1 reference

29 July 2017

1 reference

29 July 2017

1 reference